ZLD-2218

N/A

Report date: 2026/01/15 17:09:02
NME

Base Information

Drug NameZLD-2218
Drug Alias NameZLD-2218
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsRenal fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWest China Hospital Of Sichuan University
China Registration ClassN/A

Develop Information

Active CompaniesWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsRenal fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A